Synthesis and Characterization of Water-soluble Conjugates of Cabazitaxel Hemiesters-Dextran
Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.org..
BACKGROUND: Cabazitaxel (CTX) is a second- generation taxane derivative, a class of potent anticancer drugs with very low water solubility. CTX is used in patients with resistant prostate cancer unresponsive to the first generation taxane, docetaxel. Currently marketed formulations of CTX contain high concentrations of surfactant and ethanol, which cause severe hypersensitivity reactions in patients.
METHODS: In order to increase its solubility, two hemiester analogs; CTX-succinate and CTX-glutarate were synthesized and characterized. To improve the solubility of hemiesters even more, dextran as a biocompatible polymer was also conjugated to hemiester analogs. MTT assay was performed on MCF-7 cell line to evaluate the cytotoxicity effect of hemiesters and conjugates.
RESULTS: Based on the results, hemiester analogs increased water solubility of the drug up to about 3 and 8 fold. Conjugation to dextran enhanced the CTX solubility to more than 1500 fold. These conjugates released the conjugated CTX in less than 24 hours in a pH dependent manner and showed proper hemocompatibility characteristics. The hemiesters had approximately similar cytotoxicity in comparison with CTX and the dextran conjugates showed higher cytotoxicity effect on MCF-7 cell line.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2017 |
|---|---|
| Erschienen: |
2017 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:17 |
|---|---|
| Enthalten in: |
Anti-cancer agents in medicinal chemistry - 17(2017), 11 vom: 24. Nov., Seite 1555-1562 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Parhizkar, Elahehnaz [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
059QF0KO0R |
|---|
| Anmerkungen: |
Date Completed 25.12.2017 Date Revised 25.12.2017 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.2174/1871520617666170213120506 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM26961351X |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM26961351X | ||
| 003 | DE-627 | ||
| 005 | 20231224224909.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231224s2017 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.2174/1871520617666170213120506 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0898.xml |
| 035 | |a (DE-627)NLM26961351X | ||
| 035 | |a (NLM)28270079 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Parhizkar, Elahehnaz |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Synthesis and Characterization of Water-soluble Conjugates of Cabazitaxel Hemiesters-Dextran |
| 264 | 1 | |c 2017 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 25.12.2017 | ||
| 500 | |a Date Revised 25.12.2017 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.org. | ||
| 520 | |a BACKGROUND: Cabazitaxel (CTX) is a second- generation taxane derivative, a class of potent anticancer drugs with very low water solubility. CTX is used in patients with resistant prostate cancer unresponsive to the first generation taxane, docetaxel. Currently marketed formulations of CTX contain high concentrations of surfactant and ethanol, which cause severe hypersensitivity reactions in patients | ||
| 520 | |a METHODS: In order to increase its solubility, two hemiester analogs; CTX-succinate and CTX-glutarate were synthesized and characterized. To improve the solubility of hemiesters even more, dextran as a biocompatible polymer was also conjugated to hemiester analogs. MTT assay was performed on MCF-7 cell line to evaluate the cytotoxicity effect of hemiesters and conjugates | ||
| 520 | |a RESULTS: Based on the results, hemiester analogs increased water solubility of the drug up to about 3 and 8 fold. Conjugation to dextran enhanced the CTX solubility to more than 1500 fold. These conjugates released the conjugated CTX in less than 24 hours in a pH dependent manner and showed proper hemocompatibility characteristics. The hemiesters had approximately similar cytotoxicity in comparison with CTX and the dextran conjugates showed higher cytotoxicity effect on MCF-7 cell line | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Cabazitaxel | |
| 650 | 4 | |a dextran conjugates | |
| 650 | 4 | |a drugs. | |
| 650 | 4 | |a hemiesters | |
| 650 | 4 | |a pH stability | |
| 650 | 4 | |a water solubility | |
| 650 | 7 | |a Antineoplastic Agents |2 NLM | |
| 650 | 7 | |a Dextrans |2 NLM | |
| 650 | 7 | |a Taxoids |2 NLM | |
| 650 | 7 | |a Water |2 NLM | |
| 650 | 7 | |a 059QF0KO0R |2 NLM | |
| 650 | 7 | |a cabazitaxel |2 NLM | |
| 650 | 7 | |a 51F690397J |2 NLM | |
| 700 | 1 | |a Ahmadi, Fatemeh |e verfasserin |4 aut | |
| 700 | 1 | |a Daneshamouz, Saeid |e verfasserin |4 aut | |
| 700 | 1 | |a Mohammadi-Samani, Soliman |e verfasserin |4 aut | |
| 700 | 1 | |a Sakhteman, Amirhossein |e verfasserin |4 aut | |
| 700 | 1 | |a Parhizkar, Golnaz |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Anti-cancer agents in medicinal chemistry |d 2006 |g 17(2017), 11 vom: 24. Nov., Seite 1555-1562 |w (DE-627)NLM160693403 |x 1875-5992 |7 nnns |
| 773 | 1 | 8 | |g volume:17 |g year:2017 |g number:11 |g day:24 |g month:11 |g pages:1555-1562 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.2174/1871520617666170213120506 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 17 |j 2017 |e 11 |b 24 |c 11 |h 1555-1562 | ||